[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1987

Pancreatoduodenectomy in the Management of Chronic Pancreatitis

Author Affiliations

From the Department of Surgery, Lahey Clinic Medical Center, Burlington, Mass (Drs Rossi, Braasch, Munson, and ReMine); and the Department of Surgery, New England Medical Center Hospitals, Boston (Dr Rothschild).

Arch Surg. 1987;122(4):416-420. doi:10.1001/archsurg.1987.01400160042004
Abstract

• The records of 73 consecutive patients who underwent pancreatoduodenectomy for chronic pancreatitis between 1960 and 1985 were reviewed. The median size of the pancreatic duct was 5 mm. Two operative deaths (2.7%) occurred early in the series. Eighty-eight percent, 86%, and 79% of the patients had improvement in pain at six months, two years, and five years, respectively. Diabetes was present preoperatively in 25% of patients and postoperatively in 37%, 45%, and 69% of patients at six months, two years, and five years, respectively. Pancreatic enzyme preparations were used preoperatively by 26% of patients; this use increased to 75% by five years. Only four of 17 late deaths could be related to diabetes or malnutrition. In most patients, pancreatoduodenectomy achieves long-term pain improvement and permits return to normal activities. Selection of patients is important to decrease the late morbidity and mortality.

(Arch Surg 1987;122:416-420)

×